Understanding medication adherence in pediatric acute lymphoblastic leukemia: A review

Journal of Pediatric Hematology/Oncology

Volumn 28, Issue 12, 2006, Pages 816-823

  Pritchard, Michelle T ^a   Butow, Phyllis N ^a   Stevens, Michael M ^b   Duley, John A ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Acute lymphoblastic leukemia; Pediatric; Review; Treatment adherence

Indexed keywords

DRUG METABOLITE; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; PREDNISONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; CHILDHOOD CANCER; DEMOGRAPHY; DRUG DETERMINATION; ELECTRONICS; HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; RISK FACTOR; SELF REPORT; SOCIAL PSYCHOLOGY; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; PATIENT COMPLIANCE; PATIENT EDUCATION; RECURRENCE;

EID: 33845713998     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/01.mph.0000243666.79303.45     Document Type: Review

References (61)

1. Pui CH, Campana D, Evans WE. Childhood acute lymphoblastic leukaemia - current status and future perspectives. Lancet Oncol. 2001;2:597-607.
2. Tebbi CK. Treatment compliance in childhood and adolescence. Cancer Suppl. 1993;71:3441-3449.
3. Lau RCW, Matsui D, Greenberg M, et al. Electronic measurement of compliance with mercaptopurine in pediatric patients with acute lymphoblastic leukemia. Med Pediatr Oncol. 1998;30:85-90.
4. Klopovich PM, Trueworthy RC. Adherence to chemotherapy regimens among children with cancer. Top Clin Nurs. 1985;7:19-25.
5. Lilleyman JS, Lennard L. Non-compliance with oral chemotherapy in childhood leukaemia. Br Med J. 1996;313:1219-1220.
6. Davies HA, Lilleyman JS. Compliance with oral chemotherapy in childhood lymphoblastic leukaemia. Cancer Treatment Rev. 1995;21:93-103.
7. Kyngas H, Duffy ME, Kroll T. Conceptual analysis of compliance (review). J Clin Nurs. 2000;9:5-12.
8. Hentinen M, Kyngas H. Compliance of young diabetics with health regimens. J Adv Nurs. 1992;17:530-536.
9. DiNicola DD, DiMatteo MR. Practitioners, patients and compliance with medical regimens: a social psychological perspective. In: Baum A, Taylor SE, Singer JE, eds. Handbook of Psychology and Health. Social Psychological Aspects of Health. London: Lawrence Erlbaum Associates; 1984:55-84.
10. O'Hanrahan M, O'Malley K. Compliance with drug treatment. Br Med J. 1981;283:298-300.
11. Lewis C, Linet MS, Abeloff MD. Compliance with cancer therapy by patients and physicians. Am J Med. 1983;74:673-678.
12. Roter DL, Hall JA, Merisca R, et al. Effectiveness of interventions to improve patient compliance. Med Care. 1998;36:1138-1161.
13. Richardson JL, Marks G, Anderson Johnson C, et al. Path model of multidimensional compliance with cancer therapy. Health Psychol. 1987;6:183-207.
14. Tebbi CK, Cummings M, Zevon MA, et al. Compliance of pediatric and adolescent cancer patients. Cancer. 1986;58:1179-1184.
15. Festa RS, Tamaroff MH, Chasalow F, et al. Therapeutic adherence to oral medication regimens by adolescents with cancer. I. Laboratory assessment. J Pediatr. 1992;120:808-811.
16. Koren G, Ferrazini G, Sulh H, et al. Systematic exposure to 6-mercaptopurine as a prognostic factor in acute lymphoblastic leukaemia in children. N Engl J Med. 1990;323:17-21.
17. Schmiegelow K, Schroder H, Gustafsson G, et al. Risk of relapse in childhood acute lymphoblastic leukaemia is related to RBC methotrexate and mercaptopurine during maintenance chemotherapy. J Clin Oncol. 1995;13:345-351.
18. Smith SD, Rosen D, Trueworthy RC, et al. A reliable method for evaluating drug compliance in children with cancer. Cancer. 1979;43:169-173.
19. Jamison RN, Lewis S, Burish TG. Cooperation with treatment in adolescent cancer patients. J Adolesc Health Care. 1986;7:162-167.
20. Innocenti F, Danesi R, Favre C, et al. Variable correlation between 6-mercaptopurine metabolites in erythrocytes and hematologic toxicity: implications for drug monitoring in children with acute lymphoblastic leukemia. Therap Drug Monitor. 2000;22:375-382.
21. Peeters M, Koren G, Jakubovicz D, et al. Physician compliance and relapse rates of acute lymphoblastic leukemia in children. Clin Pharmocol Ther. 1988;43:228-232.
22. Lilleyman JS, Lennard L. Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia. Lancet. 1994;343:1188-1190.
23. Hicsonmez G, Ozsoylu S, Yetgin S, et al. Poor prognosis of childhood acute lymphoblastic leukaemia. Br Med J Clin Res Ed. 1983;286:1437.
24. Viana MB, Murao M, Ramos G, et al. Malnutrition as a prognostic factor in lymphoblastic leukaemia: a multivariate analysis. Arch Dis Child. 1994;71:304-310.
25. Bhatia S, Sather HN, Heerema NA, et al. Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood. 2002;100:1957-1964.
26. Lennard L, Lilleyman JS, Van Loon J, et al. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia. Lancet. 1990;336:225-229.
27. Pinkerton CR, Welshman SG, Glasgow JFT, et al. Can food influence the absorption of methotrexate in children with acute lymphoblastic leukaemia?. Lancet, ii. 1980;2:944-946.
28. MacDougall LG, Wilson TD, Cohn R, et al. Compliance with chemotherapy in childhood leukaemia in Africa. South Afr Med J. 1989;75:481-484.
29. Kyngas H, Kroll T, Duffy ME. Compliance in adolescents with chronic diseases: a review. J Adolesc Health. 2000;26:379-388.
30. Shope JT. Medication compliance. Pediatr Clin North Am. 1981;28:5-21.
31. Kennard BD, Stewart SM, Olvera R, et al. Nonadherence in adolescent oncology patients: preliminary data on psychosocial risk factors and relationships to outcome. J Clin Psychol Med Setting. 2004;11:31-39.
32. Rapoff MA, McGrath AM, Smith SD. Adherence to treatment demands. In: Brown RT, ed. Comprehensive Handbook of Childhood Cancer and Sickle Cell Disease. A Biopsychosocial Approach. New York: Oxford University Press; 2006:138-169.
33. Lau RC, Matsui D, Greenberg M, et al. Electronic measurement of compliance with mercaptopurine in pediatric patients with acute lymphoblastic leukemia. Med Pediatr Oncol. 1998;30:85-90.
34. Lansky SB, Smith SD, Cairns NU, et al. Psychological correlates of compliance. Am J Pediatr Hematol Oncol. 1983;5:87-92.
35. MacDougall LG, McElligott SE, Ross E, et al. Pattern of 6-mercaptopurine urinary excretion in children with acute lymphoblastic leukaemia: urinary assays as a measure of drug compliance. Ther Drug Monitor. 1992;14:371-375.
36. Lennard L, Lilleyman JS. Compliance with 6-mercaptopurine in UKALL trials. Br J Haematol. 1993;84(suppl):19.
37. Davies HA, Lennard L, Lilleyman JS. Variable mercaptopurine metabolism in children with leukaemia: a problem of noncompliance? Br Med J. 1993;306:1239-1240.
38. Lancaster D, Lennard L, Lilleyman JS. Profile of non-compliance in lymphoblastic leukaemia. Arch Dis Child. 1997;76:365-366.
39. Tamaroff MH, Festa RS, Adesman AR, et al. Therapeutic adherence to oral medication regimens by adolescents with cancer. II. Clinical and psychological correlates. J Pediatr. 1992;120:812-817.
40. Bearison DJ. Medication compliance in pediatric oncology. In: Bearison DJ, Mulhern RK, eds. Pediatric Psychooncology: Psychological Perspectives on Children With Cancer. New York: Oxford University Press; 1994:84-98.
41. Fielding D, Duff A. Compliance with treatment protocols: interventions for children with chronic illness. Arch Dis Child. 2005;80:196-200.
42. Olson R, Kaufman K, Ware L, et al. Compliance with treatment regimens. Semin Oncol Nurs. 1986;2:104-111.
43. Becker MH. The Health Belief Model and Personal Health Behaviour. New Jersey: Slack, Thorfare; 1974.
44. Levanthal H, Diefenbach M, Levanthal EA. Illness cognition- using common sense to understand treatment adherence and affect cognition interactions. Cogn Ther Res. 1992;16:143-163.
45. Phipps S, Fairclough DL, Mulhern RK. Avoidant coping in children with cancer. J Pediatr Psychol. 1995;20:217-232.
46. Phipps S, Srivastava DK. Repressive adaptation in children with cancer. Health Psychol. 1997;16:521-528.
47. Canning EH, Canning RD, Boyce WT. Depressive symptoms and adaptive style in children with cancer. J Am Acad Child Adolesc Psychiatry. 1992;31:1120-1124.
48. Lazarus RS, Folkman S. Stress, Appraisal and Coping. New York: Springer; 1984.
49. Delamatar AM, Kurtz SM, Bubb J, et al. Stress and coping in relation to metabolic control of adolescents with Type 1 diabetes. Dev Behav Pediatr. 1987;8:136-140.
50. Hanson CL, Cigrang JA, Harris MA, et al. Coping styles in youths with insulin-dependent diabetes mellitus. J Consult Clin Psychol. 1989;57:644-651.
51. Hamburg BA, Inoff GE. Relationships between behavioral factors and diabetic control in children and adolescents: a camp study. Psychosom Med. 1982;44:321-339.
52. Blotcky AD, Conaster C, Cohen DG, et al. Psychosocial characteristics of adolescents who refuse cancer treatment. J Consult Clin Psychol. 1985;53:729-731.
53. Eiser C, Kopel SJ. Children's Perceptions of Health and Illness. Perceptions of Health and Illness. Amsterdam: Harwood Academic Publishers; 1997:47-76.
54. Bush PJ, Iannotti RJ. A children's health belief model. Med Care. 1990;28:69-86.
55. Cummings KM, Becker MH, Kirscht JP, et al. Psychosocial factors affecting adherence to medical regimens in a group of hemodialysis patients. Med Care. 1982;20:567-580.
56. Dragone MA, Bush PJ, Jones JK, et al. Development and evaluation of an interactive CD-ROM for children with leukemia and their families. Patient Educ Counsel. 2002;46:297-307.
57. Sahler OJ, Varni J, Fairclough D, et al. Problem-solving skills training for mothers of children with newly diagnosed cancer: a randomized trial. Dev Behav Pediatr. 2002;23:77-86.
58. Streisand R, Rodrique J, Houck C, et al. Brief report: parents of children undergoing bone marrow transplantation: documenting stress and piloting a psychological intervention program. J Pediatr Psychol. 2000;25:331-337.
59. Hoekstra-Weebers J, Heuvel F, Jaspers J, et al. Brief report: an intervention program for parents of pediatric cancer patients: a randomized clinical trial. J Pediatr Psychol. 1998;23:207-214.
60. Tyc V, Rai S, Lensing S, et al. An intervention to reduce intentions to use tobacco among pediatric cancer survivors. J Clin Oncol. 2003;21:1366-1372.
61. Kazak AE. Evidence-based interventions for survivors of childhood cancer and their families. J Pedatr Psychol. 2005;30:29-39.